Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders [5]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 6, 2006, Pages 671-673

  Mann, Klaus ^a,b   Hiemke, Christoph ^a   Lotz, Johannes ^a   Schmidt, Lutz G ^a   Lackner, Karl J ^a   Bates, David W ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID;

BIPOLAR DISORDER; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL DECISION MAKING; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG MONITORING; HISTOGRAM; HOSPITAL PATIENT; HUMAN; LETTER; MAJOR DEPRESSION; MEDICAL RECORD; MENTAL PATIENT; MOOD DISORDER; PRIORITY JOURNAL; RANK SUM TEST; SAMPLE SIZE; STEADY STATE;

ANTIMANIC AGENTS; DRUG MONITORING; HOSPITALS, PSYCHIATRIC; HUMANS; INPATIENTS; LITHIUM COMPOUNDS; MOOD DISORDERS; TIME FACTORS; VALPROIC ACID;

EID: 33751099830     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000246208.11153.b6     Document Type: Letter

References (10)

1. Baumann P, Hiemke C, Ulrich S, et al. The AGNP-TDM Expert Group Consensus Guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. 2004;37:243-265.
2. Vuille F, Amey M, Baumann P. Use of plasma level monitoring of antidepressants in clinical practice. Towards an analysis of clinical utility. Pharmacopsychiatry. 1991;24:190-195.
3. Zernig G, Lechner T, Kramer-Reinstadler K, et al. What the clinician still has to be reminded of. Ther Drug Monit. 2004;26:582.
4. Schoenenberger RA, Tanasijevic MJ, Jha A, et al. Appropriateness of antiepileptic drug level monitoring. JAMA. 1995;274:1622-1626.
5. Affolter N, Krähenbühl S, Schlienger RG. Appropriateness of serum level determinations of antiepileptic drugs. Swiss Med Wkly. 2003;133:591-597.
6. Van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA. 1998;280:550-558.
7. Bates DW, Boyle DL, Rittenberg E, et al. What proportion of common diagnostic tests appear redundant? Am J Med. 1998;104:361-368.
8. Tonkin AL, Bochner F. Therapeutic drug monitoring and patient outcome. Clin Pharmacokinet. 1994;27:169-174.
9. Bates DW. Improving the use of therapeutic drug monitoring. Ther Drug Monit. 1998;20:550-555.
10. Bates DW, Kuperman GJ, Rittenberg E, et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med. 1999;106:144-150.